HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization | |
Liu, K; Yang, L; Zhang, XM; Zhou, Y; Zhu, T; Miao, ND; Ren, YJ; Xu, H; Min, XL; Peng, J | |
刊名 | TRANSLATIONAL CANCER RESEARCH |
2017 | |
卷号 | Vol.6 No.6页码:1043-1049 |
关键词 | Liver cancer chemoembolization angiogenesis treatment response |
ISSN号 | 2218-676X |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/1840491 |
专题 | 四川大学 |
作者单位 | 1.Yanan Univ, Xianyang Hosp, Dept Pain Management, Xianyang 712000, Peoples R China 2.North Sichuan Med Coll, Dept Prevent Med, Nanchong 637000, Peoples R China 3.North Sichuan Med Coll, Affiliated Hosp, Sichuan Key Lab Med Imaging, Dept Radiol, Nanchong 637000, Peoples R China |
推荐引用方式 GB/T 7714 | Liu, K,Yang, L,Zhang, XM,et al. HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization[J]. TRANSLATIONAL CANCER RESEARCH,2017,Vol.6 No.6:1043-1049. |
APA | Liu, K.,Yang, L.,Zhang, XM.,Zhou, Y.,Zhu, T.,...&Peng, J.(2017).HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization.TRANSLATIONAL CANCER RESEARCH,Vol.6 No.6,1043-1049. |
MLA | Liu, K,et al."HIF-1 alpha and VEGF levels for monitoring hepatocellular carcinoma treatment response to transcatheter arterial chemoembolization".TRANSLATIONAL CANCER RESEARCH Vol.6 No.6(2017):1043-1049. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论